The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
The Sulfate Moieties of Glycosaminoglycans Are Critical for the Enhancement of β‐Amyloid Protein Fibril Formation
Abstract
Abstract: Our previous studies have demonstrated that perlecan and perlecan‐derived glycosaminoglycans (GAGs) not only bind β‐amyloid protein (Aβ) 1‐40 and 1‐42, but are also potent enhancers of Aβ fibril formation and stabilize amyloid fibrils once formed. However, it was not determined which moieties in perlecan heparan sulfate GAG chains may be responsible for the observed effects and whether other GAGs were also capable of a similar enhancement of Aβ fibril formation as observed with perlecan GAGs. In the present study, thioflavin T fluorometry (over a 1‐week period) was used to extend our previous studies and to test the hypothesis that the sulfate moiety is critical for the enhancing effects of heparin/heparan sulfate GAGs on Aβ 1‐40 fibrillogenesis. This hypothesis was confirmed when removal of all sulfates from heparin (i.e., completely desulfated N‐acetylated heparin) led to a complete loss in the enhancement of Aβ fibrillogenesis as demonstrated in both thioflavin T fluorometry and Congo red staining studies. On the other hand, removal of O‐sulfate from heparin (i.e., completely desulfated N‐sulfated heparin), and to a lesser extent N‐sulfate (i.e., N‐desulfated N‐acetylated heparin), resulted in only a partial loss of the enhancement of Aβ 1‐40 fibril formation. These studies indicate that the sulfate moieties of GAGs are critical for enhancement of Aβ amyloid fibril formation. In addition, other sulfated molecules such as chondroitin‐4‐sulfate, dermatan sulfate, dextran sulfate, and pentosan polysulfate all significantly enhanced (greater than twofold by 3 days) Aβ amyloid fibril formation. These latter findings indicate that deposition and accumulation of other GAGs at sites of Aβ amyloid deposition in Alzheimer’s disease brain may also participate in the enhancement of Aβ amyloidosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease
Wyss-Coray, T., Masliah, E., Mallory, M., McConlogue, L., Johnson-Wood, K., Lin, C., & Mucke, L. (1997) · Nature · doi:10.1038/39321 · Cited by 417
Cited by
Heparan Sulfate: A Complex Polymer Charged with Biological Activity
Whitelock, J. M., & Iozzo, R. V. (2005) · Chemical Reviews · doi:10.1021/cr010213m · Cited by 410
Cohlberg, J. A., Li, J., Uversky, V. N., & Fink, A. L. (2002) · Biochemistry · doi:10.1021/bi011711s · Cited by 340
Sulfation of Glycosaminoglycans and Its Implications in Human Health and Disorders
Soares da Costa, D., Reis, R. L., & Pashkuleva, I. (2017) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071516-044610 · Cited by 324
Syndecans in wound healing, inflammation and vascular biology
Alexopoulou, A. N., Multhaupt, H. A. B., & Couchman, J. R. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.10.014 · Cited by 294
Karran, E., & Hardy, J. (2014) · Annals of Neurology · doi:10.1002/ana.24188 · Cited by 275
Metadata
- Authors
- Castillo, G. M., Lukito, W., Wight, T. N., & Snow, A. D.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 1999-04
- Volume
- 72
- Issue
- 4
- Pages
- 1681-1687
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2103997070
- Cited by
- 223
- References
- 1
- FWCI
- 4.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Sulfate Moieties of Glycosaminoglycans Are Critical for the Enhancement of β‐Amyloid Protein Fibril Formation. https://app.cochat.ai/papers/10.1046/j.1471-4159.1999.721681.x
- The paper
- Castillo, G. M., Lukito, W., Wight, T. N., & Snow, A. D. (1999). The Sulfate Moieties of Glycosaminoglycans Are Critical for the Enhancement of β‐Amyloid Protein Fibril Formation. Journal of Neurochemistry. https://doi.org/10.1046/j.1471-4159.1999.721681.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.